Ethan J. Haskel

Relative efficacy of antithrombin compared with antiplatelet agents in accelerating coronary thrombolysis and preventing early reocclusion.

Ethan J. Haskel, Nelson A. Prager, Burton E. Sobel et al. · Circulation · 1991 · 151 citations

Prevention of arterial reocclusion after thrombolysis with recombinant lipoprotein-associated coagulation inhibitor.

Ethan J. Haskel, Sheryl R. Torr, Kathleen C. Day et al. · Circulation · 1991 · 122 citations · Full text

Prevention of reoccluding platelet-rich thrombi in canine femoral arteries with a novel peptide antagonist of platelet glycoprotein IIb/IIIa receptors.

Ethan J. Haskel, S P Adams, Larry P. Feigen et al. · Circulation · 1989 · 66 citations · Full text

Canine Femoral Arteries, Biomedical Engineering, Thrombosis +18

Deaggregation of human platelets in vitro by an RGD analog antagonist of platelet glycoprotein IIb/IIIa receptors

Ethan J. Haskel, Dana R. Abendschein · Thrombosis Research · 1989 · 21 citations

Thrombopoiesis, Thrombosis, Rgd Analog Antagonist +11

Inhibition of cyclic flow variations and reocclusion after thrombolysis in dogs by a novel antagonist of platelet-activating factor

Sheryl R. Torr, Ethan J. Haskel, Philip F. VonVoigtlander et al. · Journal of the American College of Cardiology · 1991 · 17 citations

Thrombopoiesis, Thrombosis, Cardiovascular Disease +15